☆ 4.5 Editorial Material

Prologue: Evidence Informing the GRAPPA 2021 Treatment Recommendations, by Domain

JOURNAL OF RHEUMATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Rheumatology

Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review the 2021 GRAPPA Treatment Recommendations

Deepak R. Jadon et al.

Summary: This study summarizes the efficacy and safety of advanced therapies for psoriatic arthritis in patients with related conditions, including Crohn's disease, ulcerative colitis, and noninfectious uveitis. The tumor necrosis factor inhibitor (TNFi) class appears to be effective and safe, while interleukin 12/23 inhibitors (IL-12/23i) show efficacy in Crohn's disease and ulcerative colitis. However, caution should be exercised when using interleukin 17 inhibitors (IL-17i) in patients with psoriatic arthritis at high risk of inflammatory bowel disease.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Kristina Callis Duffin et al.

Summary: This study aimed to summarize and evaluate the current evidence on the efficacy of therapies for cutaneous psoriasis in patients with psoriatic arthritis. The findings suggest that several pharmacologic therapeutic classes have high-quality evidence demonstrating efficacy for cutaneous psoriasis in the psoriatic arthritis population.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Lihi Eder et al.

Summary: This article summarizes existing evidence regarding pharmaceutical and nonpharmaceutical interventions for enthesitis in patients with psoriatic arthritis (PsA) to facilitate an evidence-based update of the Group for Research and Assessment in Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for PsA. The article found several classes of systemic conventional and advanced therapies and local measures were recommended for active enthesitis in patients with PsA.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Cristiano B. Campanholo et al.

Summary: The 2021 GRAPPA treatment recommendations provide evidence-based guidance for selecting therapy based on individual disease features. Comorbidities also play a significant role in therapy selection for psoriatic arthritis (PsA), and need to be assessed prior to treatment selection.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Penelope Esther Palominos et al.

Summary: This literature review aimed to identify the most efficacious current interventions for dactylitis and provide up-to-date scientific evidence to support the 2021 GRAPPA recommendations on the management of psoriatic arthritis. The analysis of original articles revealed a lack of consensus regarding dactylitis assessment and the paucity of data concerning the effect of certain medications.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Dhruvkumar Laheru et al.

Summary: This article updates the treatment recommendations for nail psoriasis, and suggests that biologic agents are the preferred treatment option.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Ennio Lubrano et al.

Summary: Objective. The objective of this study was to identify and evaluate the efficacy of therapeutic interventions for treatment of axial disease in PsA. Methods. This systematic review updated the treatment recommendations for axial PsA. Results. The literature review revealed that new biologic and targeted synthetic disease-modifying antirheumatic drug classes could be considered for the treatment of axial PsA. Conclusion. Further studies are needed for a better understanding of the treatment of axial PsA.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Review Rheumatology

Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Ying-Ying Leung et al.

Summary: The objective of this study was to provide evidence for the efficacy and safety of therapeutic options for the peripheral arthritis domain of PsA for the revised 2021 GRAPPA treatment recommendations. Evidence was derived from new RCTs and recommendations were made for different patient groups based on their treatment history and response. Different classes of therapeutic options were strongly recommended for different patient groups.

JOURNAL OF RHEUMATOLOGY (2023)

Add to Collection

Article Rheumatology

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Laura C. Coates et al.

Summary: This article presents evidence-based treatment recommendations for Psoriatic Arthritis (PsA) medication selection, covering various clinical domains, related conditions and comorbidities. It provides important guidance and support for clinicians and individuals with PsA.

NATURE REVIEWS RHEUMATOLOGY (2022)

Add to Collection

Review Rheumatology

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope

William Tillett et al.

Summary: This guideline aims to provide updated evidence-based recommendations for the treatment of adult patients with PsA, including the optimal selection of advanced therapies and treatment strategies, with NICE accreditation.

RHEUMATOLOGY (2021)

Add to Collection

Review Rheumatology

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Laure Gossec et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Add to Collection

Article Rheumatology

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh et al.

ARTHRITIS CARE & RESEARCH (2019)

Add to Collection

Review Rheumatology

Treatment recommendations for psoriatic arthritis

C. T. Ritchlin et al.

ANNALS OF THE RHEUMATIC DISEASES (2009)

Add to Collection

Article Rheumatology

Classification criteria for psoriatic arthritis - Development of new criteria from a large international study

William Taylor et al.

ARTHRITIS AND RHEUMATISM (2006)

Add to Collection

Review Rheumatology

Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis

MJ Peters et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.